Sexually transmitted infections among pre-exposure prophylaxis users in a Swedish multi-centre cohort
Open Access
- 4 April 2025
- journal article
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 35 (4) , 752-759
Abstract
An additional upsurge in bacterial STIs has been observed in Sweden following HIV pre-exposure prophylaxis (PrEP) implementation. From a prevention perspective, it is of relevance to optimize testing strategies within PrEP programmes to identify those most at risk. An open retrospective longitudinal observational cohort study was performed at three STI clinics in Uppsala, Gothenburg, and Malmö. A questionnaire and journal data regarding STI were collected from a sample of 199 MSM enrolled in the PrEP programmes and providing informed consent. Incident bacterial STIs during follow-up were analyzed with descriptive statistics, Poisson regression, and Cox regression. Median follow-up time was 632 days. A total of 270 gonorrhoea or chlamydia infections were recorded during PrEP follow-up, compared to 194 cases in the 2-year period prior to enrolment, giving an incidence rate ratio (IRR) of 1.56 (CI 95% 1.30–1.89). The testing frequency increased by 75% (IRR 1.69, CI 95% 1.60–1.90). For diagnoses of active syphilis, the increase was 108% (IRR 2.08. CI 95% 1.04–4.06), compared with a 5-year period preceding enrolment. The hazard ratio of time (days) until a first STI after PrEP initiation was 2.87 (CI 95% 1.72–4.80) for those having had a STI prior to PrEP initiation and 2.06 (CI 95% 1.03–4.13) for those reporting experience of group sex in the past year compared with those who had not. STI prior to PrEP initiation and group sex were associated with STI after initiation of PrEP, factors that could be considered if needing prioritizing the frequency of STI screening.Keywords
Funding Information
- Uppsala University Hospital
- Public Health Agency of Sweden
This publication has 22 references indexed in Scilit:
- Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trialThe Lancet HIV, 2024
- Preventing Disease, Not Sex—Harm Reduction, HIV Preexposure Prophylaxis, and Sexually Transmitted InfectionsJAMA Network Open, 2020
- Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With MenJAMA Network Open, 2020
- The Traditional or Reverse Algorithm for Diagnosis of Syphilis: Pros and ConsClinical Infectious Diseases, 2020
- Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration studyThe Lancet HIV, 2019
- Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV InfectionJAMA, 2019
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialThe Lancet, 2016
- On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 InfectionNew England Journal of Medicine, 2015
- Determinants of social desirability bias in sensitive surveys: a literature reviewQuality & Quantity, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010